The LEX system brings together high speed and high sensitivity in a PCR molecular system to redefine point-of-care diagnostics. Our launch product will complete a test in under 10 minutes while reporting positive results in as little as 6 minutes, enabling time and cost-efficient results during a single appointment.

animated image
Point-of-care molecular diagnostics with a step change in speed, sensitivity and cost

At launch, the LEX system will report positive results in as little as 6 minutes with multiplex testing for the detection and differentiation of Flu A, Flu B and COVID-19, while negative results will report in under 10 minutes. The system is designed for use in CLIA waived settings with a fully automated swab-to-result workflow that requires no liquid sample handling, saving hands-on time and reducing the risk of infection. The compact footprint is intended for use at the point of care in a physician’s office, pharmacy or urgent care facility.

LEX plans to expand respiratory test offering by developing RSV and Strep A tests.

Latest News
July 18, 2023
LEX Diagnostics Appoints Chief Technology Officer
0
0
0
Get in touch
Learn more about our company and the science behind our ultra-fast diagnostics platform.